Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas.

EBioMedicine · 2025 · PMC12278414 · PMID 40562609

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly significantno p-value reported

Comparison between NF2 clusters 1 and 2 also shows slightly significant reduction of ANXA3 in NF2-Cluster 1 in our mass spec data ( Supplementary Fig.

also in 1,762 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.